361 related articles for article (PubMed ID: 23816051)
21. Tumourigenic canine osteosarcoma cell lines associated with frizzled-6 up-regulation and enhanced side population cell frequency.
de Sá Rodrigues LC; Holmes KE; Thompson V; Newton MA; Stein TJ
Vet Comp Oncol; 2017 Mar; 15(1):78-93. PubMed ID: 25689105
[TBL] [Abstract][Full Text] [Related]
22. How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize.
Hughes DP
Cancer Treat Res; 2009; 152():479-96. PubMed ID: 20213410
[TBL] [Abstract][Full Text] [Related]
23. Expression of platelet-derived growth factor BB, erythropoietin and erythropoietin receptor in canine and feline osteosarcoma.
Meyer FR; Steinborn R; Grausgruber H; Wolfesberger B; Walter I
Vet J; 2015 Oct; 206(1):67-74. PubMed ID: 26189892
[TBL] [Abstract][Full Text] [Related]
24. Wnt10b activates the Wnt, notch, and NFκB pathways in U2OS osteosarcoma cells.
Mödder UI; Oursler MJ; Khosla S; Monroe DG
J Cell Biochem; 2011 May; 112(5):1392-402. PubMed ID: 21321991
[TBL] [Abstract][Full Text] [Related]
25. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma.
Bennani-Baiti IM; Aryee DN; Ban J; Machado I; Kauer M; Mühlbacher K; Amann G; Llombart-Bosch A; Kovar H
J Pathol; 2011 Nov; 225(3):353-63. PubMed ID: 21984123
[TBL] [Abstract][Full Text] [Related]
26. Glucose transporter 1 expression in canine osteosarcoma.
Petty JC; Lana SE; Thamm DH; Charles JB; Bachand AM; Bush JM; Ehrhart EJ
Vet Comp Oncol; 2008 Jun; 6(2):133-40. PubMed ID: 19178673
[TBL] [Abstract][Full Text] [Related]
27. MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines.
Lopez CM; Yu PY; Zhang X; Yilmaz AS; London CA; Fenger JM
PLoS One; 2018; 13(1):e0190086. PubMed ID: 29293555
[TBL] [Abstract][Full Text] [Related]
28. Inactivation of p53 and retinoblastoma family pathways in canine osteosarcoma cell lines.
Levine RA; Fleischli MA
Vet Pathol; 2000 Jan; 37(1):54-61. PubMed ID: 10643981
[TBL] [Abstract][Full Text] [Related]
29. Cyclooxygenase-2 expression in canine appendicular osteosarcomas.
Mullins MN; Lana SE; Dernell WS; Ogilvie GK; Withrow SJ; Ehrhart EJ
J Vet Intern Med; 2004; 18(6):859-65. PubMed ID: 15638270
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma.
Bongiovanni L; Mazzocchetti F; Malatesta D; Romanucci M; Ciccarelli A; Buracco P; De Maria R; Palmieri C; Martano M; Morello E; Maniscalco L; Della Salda L
BMC Vet Res; 2012 Jun; 8():78. PubMed ID: 22686277
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the Notch signaling pathway attenuates progression of cell motility, metastasis, and epithelial-to-mesenchymal transition-like phenomena induced by low concentrations of cisplatin in osteosarcoma.
Dai G; Liu G; Zheng D; Song Q
Eur J Pharmacol; 2021 May; 899():174058. PubMed ID: 33757752
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant therapy with carboplatin and pamidronate for canine appendicular osteosarcoma.
Kozicki AR; Robat C; Chun R; Kurzman ID
Vet Comp Oncol; 2015 Sep; 13(3):229-36. PubMed ID: 23663234
[TBL] [Abstract][Full Text] [Related]
33. Melarsomine suppresses canine osteosarcoma cell survival via inhibition of Hedgehog-GLI signaling.
Nam A; Kim T; Li Q; Rebhun RB; Youn HY; Seo KW
J Vet Med Sci; 2019 Dec; 81(12):1722-1729. PubMed ID: 31645504
[TBL] [Abstract][Full Text] [Related]
34. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.
Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R
Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.
McMahon M; Mathie T; Stingle N; Romansik E; Vail D; London C
J Vet Intern Med; 2011; 25(3):511-7. PubMed ID: 21488959
[TBL] [Abstract][Full Text] [Related]
36. Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype.
Jackson M; Serada N; Sheehan M; Srinivasan S; Mason N; Guha M; Avadhani N
PLoS One; 2018; 13(12):e0209489. PubMed ID: 30576337
[TBL] [Abstract][Full Text] [Related]
37. Cathepsin K expression and activity in canine osteosarcoma.
Schmit JM; Pondenis HC; Barger AM; Borst LB; Garrett LD; Wypij JM; Neumann ZL; Fan TM
J Vet Intern Med; 2012; 26(1):126-34. PubMed ID: 22171552
[TBL] [Abstract][Full Text] [Related]
38. Association between absolute tumor burden and serum bone-specific alkaline phosphatase in canine appendicular osteosarcoma.
Sternberg RA; Pondenis HC; Yang X; Mitchell MA; O'Brien RT; Garrett LD; Helferich WG; Hoffmann WE; Fan TM
J Vet Intern Med; 2013; 27(4):955-63. PubMed ID: 23734720
[TBL] [Abstract][Full Text] [Related]
39. Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis.
Selvarajah GT; Verheije MH; Kik M; Slob A; Rottier PJ; Mol JA; Kirpensteijn J
Vet J; 2012 Aug; 193(2):412-9. PubMed ID: 22436430
[TBL] [Abstract][Full Text] [Related]
40. Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis.
Zheng X; Tsuchiya K; Okamoto R; Iwasaki M; Kano Y; Sakamoto N; Nakamura T; Watanabe M
Inflamm Bowel Dis; 2011 Nov; 17(11):2251-60. PubMed ID: 21987298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
